undefined

John Barkett

Managing director of BRG’s healthcare transactions and strategy practice and former senior policy advisor for healthcare delivery system reform on the White House Domestic Policy Council. Expert in drug pricing policy and its political implications.

Best podcasts with John Barkett

Ranked by the Snipd community
undefined
Nov 1, 2024 • 17min

Drug pricing and the 2024 presidential election

John Barkett, a healthcare policy expert and former senior advisor on the White House Domestic Policy Council, dives into the pivotal role of the 2024 presidential election in shaping drug pricing. He contrasts Kamala Harris and Donald Trump's approaches to reducing drug costs, emphasizing how the Inflation Reduction Act might influence their strategies. The discussion also covers Medicare negotiations, the historical context of drug pricing reforms, and Project 2025's implications, all underscoring the complex intersection of policy, politics, and pharmaceutical innovation.